Labcorp is closing its Bedford facility, laying off close to 100 positions. The global life sciences and health care company did not explain why it is closing the facility. The health care company Labcorp has notified the state that it is laying off 94 employees and closing its Bedford facility. The layoffs will begin on March 9, with most positions eliminated and a few reassigned to remote or nearby worksites. According to Labcorp's 2024 annual report, the latest available, the company owned its Bedford facility at 15 Wiggins Ave. It also leased facilities in Westborough and Holyoke. Labcorp is a global company that provides diagnostic services and drug development for patients and physicians. The company had nearly 70,000 employees in about 100 countries and supported more than 75% of the new drugs and therapeutic products approved by the FDA in 2024. Labcorp also performed more than 700 million tests annually for patients worldwide. The company had nearly 2,200 patient service centers and more than 6,800 in-office phlebotomists located in customer offices and facilities. The company is headquartered in Burlington, North Carolina, and reported annual revenue of over $13 billion in 2024. The company did not respond to additional questions about why it is closing the facility. Beth Treffeisen is a general assignment reporter for Boston.com, focusing on local news, crime, and business in the New England region.

IMVARIA, a Berkeley-based health tech company developing AI-driven digital biomarker solutions, has announced strategic investments from new and existing investors. InHealth Ventures, an early-stage fund linked to screening and diagnostics provider InHealth Group, led the funding round. The Labcorp Venture Fund and existing partner Cedar Crest Holdings also participated in the investment. The funding will be used to accelerate IMVARIA's growth and advance innovation in AI-driven digital healthcare. The company did not disclose the investment amount or valuation.

Labcorp to speak at the 44th Annual J.P. Morgan Healthcare Conference. BURLINGTON, N.C., Dec. 30, 2025 /PRNewswire/ - Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT. A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay. About Labcorp Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Andalusia Star News provide insights and advance science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about The Andalusia Star News at www.labcorp.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302650873.html SOURCE Labcorp Holdings Inc